Digoxin enhances radiation response in radioresistant A549 cells by reducing protein phosphatase 2A
Open Access
- 22 November 2017
- journal article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 37 (6)
- https://doi.org/10.1042/bsr20171257
Abstract
Protein phosphatase 2A (PP2A) is a ubiquitous multifunctional enzyme usually known as a tumor suppressor. Recent studies have reported that although inhibition of PP2A leads to acceleration of cell growth, it also induces damaged cells to pass through the cell cycle and renders them sensitive to radiotherapy. Here, we investigated the radiosensitizing effects of digoxin as a PP2A inhibitor in two non-small-cell lung cancer (NSCLC) cell types (H460 and A549) with differential sensitivity to radiation. Digoxin inhibited the proliferation of H460 and A549 cells in a dose-dependent fashion and was especially effective on radioresistant A549 cells. Interestingly, the radiosensitizing effect of digoxin was only present in the radioresistant A549 cells and xenografts. The combination of digoxin and ionizing radiation (IR) significantly reduced clonogenic survival and xenograft tumor growth (PP<0.001). In conclusion, digoxin has a novel function as a PP2A inhibitor, and combined with IR produces a synergistic effect on radiosensitizing cells, thereby indicating a potentially promising therapeutic approach to radioresistant lung cancer treatment.This publication has 32 references indexed in Scilit:
- The mechanisms of radioresistance in esophageal squamous cell carcinoma and current strategies in radiosensitivityJournal of Thoracic Disease, 2017
- Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in GlioblastomaMolecular Cancer Therapeutics, 2015
- Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancerOncotarget, 2015
- Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cellsToxicology and Applied Pharmacology, 2012
- Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathwayEuropean Journal of Cancer, 2011
- The POPX2 phosphatase regulates cancer cell motility and invasivenessCell Cycle, 2010
- WIP1 phosphatase is a negative regulator of NF-κB signallingNature, 2009
- γ-H2AX Dephosphorylation by Protein Phosphatase 2A Facilitates DNA Double-Strand Break RepairMolecular Cell, 2005
- Enhancement of radiotherapy by oleandrin is a caspase-3 dependent processCancer Letters, 2002
- Is digitalis a therapy for breast carcinoma?Oncology Reports, 1999